Dr Stephen Glen Davis Ii, PSYD | |
222 Butte St, Yreka, CA 96097-3003 | |
(530) 905-0176 | |
Not Available |
Full Name | Dr Stephen Glen Davis Ii |
---|---|
Gender | Male |
Speciality | Clinical Psychologist |
Experience | 15 Years |
Location | 222 Butte St, Yreka, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063892164 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | PSY25207 (California) | Primary |
Entity Name | Department Of State Hospitals |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1124078704 PECOS PAC ID: 9638174238 Enrollment ID: O20081031000305 |
News Archive
This week at the annual meeting of the American Academy of Pediatrics, the Vaccine Education Center at The Children's Hospital of Philadelphia (VEC) and the American Medical Association released an updated information guide called Vaccines and Teens for parents and physicians, detailing the most current recommendations and information about critical immunizations for older children.
What we need in order to address this fiscal abyss is a Grand Bargain that addresses the two main drivers of our structural deficits: unsustainable social insurance programs, especially health care programs, and a complex, unfair, uncompetitive and inadequate tax system. But a lame duck Congress cannot and should not tackle comprehensive tax and social insurance reforms.
As part of GE Healthcare's ongoing commitment to provide resources for those living with movement disorders, the company announced today a new online patient and caregiver resource - www.Move2Answers.com.
While hospitals have made strides in reducing the time it takes to treat heart attack patients once they arrive at the hospital, patient delays recognizing symptoms and seeking treatment are associated with increased damage to the heart, according to a study published online today in JACC: Cardiovascular Interventions.
A newly developed antifungal, isavuconazole, is as effective as an existing drug, voriconazole, against invasive mold disease in cancer patients with less adverse effects, according to phase 3 clinical data presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, an infectious disease meeting of the American Society for Microbiology.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Stephen Glen Davis Ii, PSYD 222 Butte St, Yreka, CA 96097-3003 Ph: (530) 905-0176 | Dr Stephen Glen Davis Ii, PSYD 222 Butte St, Yreka, CA 96097-3003 Ph: (530) 905-0176 |
News Archive
This week at the annual meeting of the American Academy of Pediatrics, the Vaccine Education Center at The Children's Hospital of Philadelphia (VEC) and the American Medical Association released an updated information guide called Vaccines and Teens for parents and physicians, detailing the most current recommendations and information about critical immunizations for older children.
What we need in order to address this fiscal abyss is a Grand Bargain that addresses the two main drivers of our structural deficits: unsustainable social insurance programs, especially health care programs, and a complex, unfair, uncompetitive and inadequate tax system. But a lame duck Congress cannot and should not tackle comprehensive tax and social insurance reforms.
As part of GE Healthcare's ongoing commitment to provide resources for those living with movement disorders, the company announced today a new online patient and caregiver resource - www.Move2Answers.com.
While hospitals have made strides in reducing the time it takes to treat heart attack patients once they arrive at the hospital, patient delays recognizing symptoms and seeking treatment are associated with increased damage to the heart, according to a study published online today in JACC: Cardiovascular Interventions.
A newly developed antifungal, isavuconazole, is as effective as an existing drug, voriconazole, against invasive mold disease in cancer patients with less adverse effects, according to phase 3 clinical data presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, an infectious disease meeting of the American Society for Microbiology.
› Verified 6 days ago
Heather Collins, SCHOOL PSY (WAIVER) Psychologist Medicare: Not Enrolled in Medicare Practice Location: 609 S Gold St, Yreka, CA 96097 Phone: 530-842-8466 | |
Dr. Kristin Rene Kopplin, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1515 South Oregon Street, Suite A, Yreka, CA 96097 Phone: 530-842-3455 Fax: 530-842-7917 | |
Dr. Henry Anthony Scheving Jr., PSY.D. Psychologist Medicare: Medicare Enrolled Practice Location: 1217 S Main St Ste D, Yreka, CA 96097 Phone: 209-588-6984 | |
Dr. Anne J Kramer, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 609 S Gold St, Yreka, CA 96097 Phone: 530-842-8432 Fax: 530-842-8435 | |
Dr. Sarah Gates Collard, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 2060 Campus Dr, Yreka, CA 96097 Phone: 541-890-0034 |